06/20/2025
7:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
11:11 AM | CFIC-2015 NV Family Investments, LLC (Reporting)
Cherng Andrew Jin-Chan (Reporting)
CHERNG PEGGY (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
11:12 AM | CFIC-2015 NV Family Investments, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
| Form SCHEDULE 13D | |
05/20/2025
7:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
11:29 AM | METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
| Form SCHEDULE 13G/A | |
05/08/2025
7:06 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
4:09 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form NT 10-K | |
03/11/2025
8:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
12:45 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 424B3 | |
03/04/2025
5:34 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/28/2025
4:46 PM | NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
PATHSTONE FAMILY OFFICE, LLC (Filed by)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for NKGNW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. |
02/25/2025
3:30 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
9:34 AM | METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
| Form SCHEDULE 13G/A | |
02/03/2025
7:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form DEF 14A | |
01/08/2025
4:29 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:54 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
6:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
6:20 PM | Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:01 PM | Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:23 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:55 PM | Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:56 PM | NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Song Paul Y. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:56 PM | Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:56 PM | NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Scott Kathleen D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:10 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
3:30 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
4:22 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:01 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
5:06 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
5:05 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
4:25 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:00 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
3:30 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
5:09 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
3:30 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
4:16 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/11/2024
4:26 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
6:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
7:00 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
5:45 PM | CFIC-2015 NV Family Investments, LLC (Reporting)
Cherng Andrew Jin-Chan (Reporting)
CHERNG PEGGY (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/22/2024
4:22 PM | CFIC-2015 NV Family Investments, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
| Form SC 13G | |
3..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad) I just put together an urgent new presentation that you need to see right away.
In short: I believe we are mere days away from a critical announcement from a key tech leader…
One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.  Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
08/22/2024
3:42 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
7:31 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form ARS | |
07/22/2024
4:19 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form DEF 14A | |
07/18/2024
4:52 PM | Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
4:53 PM | Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:25 PM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
7:15 AM | NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
